ASTRANA HEALTH INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$36.53
-0.25%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+4.6%
3 months
+1.7%
6 months
+4.7%
1 year
+14.8%
Year to date
+47.2%
52-week range
$18.16 – $49.81
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$2.04B
P/E
50.2
P/B
2.5
P/S
0.5
Revenue
$3.84B
Net income
$40.55M
Diluted EPS
0.83
Gross margin
10.50%
Net margin
1.10%
Return on equity
5.10%
Total debt
$979.41M
Cash
$400.79M
Free cash flow
$94.38M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $972.52M | $19.74M | 10.70% | 2.00% | $28.87M |
| Mar 31, 2026 | $965.1M | $14.44M | 11.00% | 1.50% | $64.06M |
| Dec 31, 2025 | $950.53M | $6M | 10.00% | 0.60% | -$5.95M |
| Sep 30, 2025 | $956.05M | $373K | 10.20% | 0.00% | $7.4M |
| Jun 30, 2025 | $654.81M | $9.42M | 11.90% | 1.40% | $89.48M |
| Mar 31, 2025 | $620.39M | $6.69M | 11.50% | 1.10% | $13.56M |
| Dec 31, 2024 | $665.21M | -$6.95M | 7.60% | -1.00% | -$13.48M |
| Sep 30, 2024 | $478.71M | $16.09M | 15.40% | 3.40% | $31.69M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ASTH news
All market newsNo ticker-linked stories are in the current archive.